Literature DB >> 15177322

The management of neuropathic pain.

Jacob Schwarz1, Neal Naff.   

Abstract

Although the definitive treatment for neuropathic pain remains elusive, scientific investigation continues to provide the field with better and better therapies. As our understanding of the neurophysiologic mechanisms of pain improves, pharmaceutic therapies have become more effective even as side effects are minimized. Surgical therapies have become more precise and less invasive. Advances in neurophysiology have given rise to new advances in the field of neuro-modulation. As this therapy continues to emerge, ablative procedures recede as therapies offering minimal invasiveness, reversible mechanisms, and long-standing relief emerge to the forefront of treatment for neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177322     DOI: 10.1016/j.nec.2004.01.001

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  2 in total

1.  Alteration of primary afferent activity following inferior alveolar nerve transection in rats.

Authors:  Kazuharu Nakagawa; Mamoru Takeda; Yoshiyuki Tsuboi; Masahiro Kondo; Junichi Kitagawa; Shigeji Matsumoto; Azusa Kobayashi; Barry J Sessle; Masamichi Shinoda; Koichi Iwata
Journal:  Mol Pain       Date:  2010-02-03       Impact factor: 3.395

Review 2.  Potassium channels as a potential therapeutic target for trigeminal neuropathic and inflammatory pain.

Authors:  Mamoru Takeda; Yoshiyuki Tsuboi; Junichi Kitagawa; Kazuharu Nakagawa; Koichi Iwata; Shigeji Matsumoto
Journal:  Mol Pain       Date:  2011-01-10       Impact factor: 3.395

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.